Does fondaparinux prevent venous thromboembolic events in older acute medical patients?
Fondaparinux effectively prevents venous thromboembolism in older acute medical patients without increasing major bleeding compared to placebo.
Fondaparinux is effective in the prevention of asymptomatic and symptomatic venous thromboembolic events in older acute medical patients. The frequency of major bleeding was similar for both fondaparinux and placebo treated patients.
Cohen et al. (Thu,) studied this question.